Re:The Villain of CRISPR
by hmahncke on Monday January 25, 2016 @03:29PM
(#10969714)
Yes, exclusively licensing CRISPR on an indication-by-indication basis as a therapeutic itself (as someone below has suggested has already happened by Broad) would be worrisome.
[ Parent
| on HN ]
There are no comments on this comment yet.